A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 689-699

  Roberts, Stephen A ^a   Hendry, Jolyon H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Head and neck tumors; Heterogeneity; Larynx cancer; Linear quadratic models; Mathematical models; Time factors

Indexed keywords

ARTICLE; CANCER CONTROL; DOSE RESPONSE; HEAD AND NECK CANCER; LARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; STATISTICAL MODEL;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LIKELIHOOD FUNCTIONS; LINEAR MODELS; MODELS, BIOLOGICAL; PHARYNGEAL NEOPLASMS; RADIOBIOLOGY;

EID: 0031749752     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00100-X     Document Type: Article

References (36)

1. Fisher J.J., Moulder J.E. The steepness of the dose-response curve in radiation therapy. Radiology. 117:1975;179-184.
2. Moore J.V., Hendry J.H., Hunter R.D. Dose-incidence curves for tumour control and normal tissue injury in relation to the response of clonogenic cells. Radiother. Oncol. 1:1983;143-157.
3. Zagars G.K., Schultheiss T.E., Peters L.J. Inter-tumour heterogeneity and radiation dose-control curves. Radiother. Oncol. 8:1987;353-362.
4. Tucker S.L., Thames H.D. Jr. The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy A theoretical evaluation . Int. J. Radiat. Oncol. Biol. Phys. 17:1989;145-147.
5. Bentzen S.M. Steepness of the clinical dose-control curve and variation in the in vitro sensitivity of head and neck squamous cell carcinoma. Int. J. Radiat. Biol. 61:1992;417-423.
6. West C.M.L. Predictive assays in radiation therapy. Adv. Radiat. Biol. 18:1994;149-180.
7. Thames H.D., Bentzen S.M., Turesson I., Overgaad M., Van den Bogaert W. Time-dose factors in radiotherapy a review of the human data . Radiother. Oncol. 19:1990;219-235.
8. Maciejewski B., Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother. Oncol. 21:1991;163-170.
9. Hendry J.H., Roberts S.A., Slevin N.J., Keane T.J., Barton M.B., Ågren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer comparisons between centres in Manchester, UK and Toronto, Canada . Radiother. Oncol. 31:1994;14-22.
10. Roberts S.A., Hendry J.H., Brewster A.E., Slevin N.J. The influence of radiotherapy treatment time on the control of laryngeal cancer a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor . Br. J. Radiol. 67:1994;790-794.
11. Withers H.R., Peters L.J., Taylor J.M.G., Owen J.B., Morrison W.H., Schultheiss T.E., Keane T., O'Sullivan B., van Dyk J., Gupta N., Wang C.C., Jones C.U., Doppke K.P., Myint S., Thompson M., Parsons J.T., Mendenhall W.M., Dische S., Aird E.G.A., Henk M., Bidmead M.A.M., Svoboda V., Chon Y., Hanlon A.L., Peters T.L., Hanks G.E. Local control of carcinoma of the tonsil An analysis of patterns of fractionation in nine institutions . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;549-562.
12. Roberts S.A., Hendry J.H. The delay before onset of accelerated tumour cell repopulation during radiotherapy a direct maximum-likelihood analysis of a collection of worldwide tumour control data . Radiother. Oncol. 29:1993;69-74.
13. Brock W.A., Baker F.L., Peters L.J. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int. J. Radiat. Biol. 56:1989;751-760.
14. Girinsky T., Lubin R., Pignon J.P., Chavaudra N., Gazeau J., Dubray B., Cosset J.M., Socie G., Fertil B. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas Preliminary correlations with local control and overall survival . Int. J. Radiat. Oncol. Biol. Phys. 25:1992;3-7.
15. Rofstad E.K., Wahl A., Brustad T. Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. Cancer Res. 47:1987;106-110.
16. Begg A.C., Hofland I., Van Glabekke M., Bartelink H., Horiot J.C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients Results from the EORTC cooperative trial 22851 . Semin. Radiat. Oncol. 2:1992;22-25.
17. Lochrin C.A., Wilson G.D., McNally N.J., Dische S., Saunders M.I. Tumor cell kinetics, local tumour control and accelerated radiotherapy A preliminary report . Int. J. Radiat. Oncol. Biol. Phys. 24:1993;87-91.
18. Bourhis J., Wilson G., Wibault P., Bosq J., Chavaudra N., Janot F., Luboinski B., Eschwege F., Malaise E.P. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;793-799.
19. Corvò R., Giaretti W., Sanguineti G., Geido E., Orecchia R., Barra S., Margarino G., Bacigalupo A., Vitale V. Potential doubling time in head and neck tumors treated by primary radiotherapy Preliminary evidence for a prognostic significance in local control . Int. J. Radiat. Oncol. Biol. Phys. 27:1993;1165-1172.
20. Bentzen S.M., Thames H.D., Overgaard J. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melonoma? Int. J. Radiat. Biol. 57:1990;117-126.
21. Thames H.D., Schultheiss T.E., Hendry J.H., Tucker S.L., Dubray B.M., Brock W.A. Can modest escalations of dose be detected as increased tumour control? Int. J. Radiat. Oncol. Biol. Phys. 22:1991;241-246.
22. Agren-Cronqvist A., Kallman P., Turesson I., Brahme A. Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours. Acta Oncol. 34:1995;851-860.
23. Hendry J.H., West C.M.L., Moore J.V., Potten C.S. Tumour stem cells the relevance of predictive assays to tumor control after radiotherapy . Radiother. Oncol. 30:1994;11-16.
24. Withers R.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
25. Wiernik G., Alcock C.J., Bates T.D., Brindle J.M., Fowler J.F., Gajek W.R., Goodman S., Haybittle J.L., Henk J.M., Hopewell J.W., Hunter R.D., Lindup R., Phillips D.L., Rezvani M. Final report on the second British Institute of Radiology fractionation study Short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx . Br. J. Radiol. 64:1991;232-241.
26. Wiernik G., Bates T.D., Bleehen N.M., Brindle J.M., Bullimore J., Fowler J.F., Haybittle J.L., Howard N., Laing A.H., Lindup R., McGurk F., Phillips D.L., Rezvani M. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br. J. Radiol. 63:1990;169-180.
27. Tucker S.L., Travis E.L. Comments on a time-dependent version of the linear quadratic model. Radiother. Oncol. 18:1990;155-163.
28. Dubray B.M., Thames H.D. The clinical significance of ratios of radiobiological parameters. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;1099-1111.
29. Thames H.D., Rozell M.E., Tucker S.L., Ang K.K., Fisher D.R., Travis E.L. Direct analysis of quantal radiation response data. Int. J. Radiat. Oncol. Biol. 49:1986;999-1009.
30. Hansen O., Grau C., Bentzen S.M., Overgaard J. Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo - in vitro excision assay. Radiother. Oncol. 39:1996;137-144.
31. Tucker S.L., Geara F.B., Peters L.J., Brock W.A. How much could radiotherapy dose be altered for individual patients based on a predictive assay of normal tissue radiosensitivity. Radiother. Oncol. 38:1996;103-113.
32. Tucker S.L., Taylor J.M.G. Improved models of tumour cure. Int. J. Radiat. Biol. 70:1996;539-553.
33. Tucker S.L., Thames H.D., Taylor J.M.G. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat. Res. 124:1990;273-282.
34. 3 laryngeal cancer using radiotherapy. Radiother. Oncol. 24:1992;215-220.
35. Bentzen S.M., Thames H.D. Clinical evidence for tumor clonogen regeneration interpretations of the data . Radiother. Oncol. 22:1991;161-166.
36. Thames H.D., Bentzen S.M. Time factor for tonsillar carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;755-758.